PARTNERSHIPS & COLLABORATIONS
Rambam Medtech, Israel
Pharmachal and tier-1 Israeli trauma hospital Rambam Health Care Campus are co-developing a new product that combines Pharmachal’s NOPAYNE mini-emulsion drug delivery technology, lidocaine, and a novel peptide drug developed at Rambam that has shown significant potential to speed up wound healing, coagulate bleeding, and encourage the formation of new blood vessels.
Magenta Investments, United Arab Emirates
Pharmachal is working with leading healthcare company Magenta Investments to distribute several products in the United Arab Emirates and GCC countries.
Fiona Stanley Hospital, State Burns Service, Perth, Western Australia
Renowned burns specialist Professor Fiona Woods AO has supported the development of NOPAYNE as principal investigator and as a technical advisor to the company.
https://www.fionastanley.health.wa.gov.au/Our-services/Service-Directory/Burns
Roosevelt Hospital, Paediatric Burns Unit, Guatemala City
Pharmachal has supplied burns products such as NOPAYNE to the Paediatric Burns Unit, led by Dr Lourdes Santiso.
Academic Institutions
